Ischaemic heart disease is Malaysia’s leading cause of medically certified deaths. With a significant cardiovascular disease burden and growing demand for effective treatments, Malaysia presents a high-impact opportunity for cardiovascular clinical trials.
Learn more from CRM’s Cardiovascular Disease Fact Sheet.
Learn more from CRM’s Cardiovascular Disease Fact Sheet.